Abstract
This article is a transcribed and lightly edited version of Patrick O’Sullivan’s oral presentation to a seminar hosted on 1 June 2023 by the Pharmaceutical Regulatory Science Team (PRST), TU Dublin, titled ICH Q9(R1): The Next Frontier – An audience with international thought leaders exploring how the effective use of knowledge can enhance QRM outcomes to benefit the patient. Patrick presented an overview of how one could leverage advanced analytics in the pharmaceutical Industry.
Recommended Citation
O'Sullivan, Patrick
(2023)
"Leveraging Advanced Analytics in the Pharmaceutical Industry,"
Level 3:
Vol. 19:
Iss.
1, Article 10.
doi:https://doi.org/10.21427/pvxd-yx20
Available at:
https://arrow.tudublin.ie/level3/vol19/iss1/10
DOI
https://doi.org/10.21427/pvxd-yx20
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.